Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Subjects With Allergic Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03680131
What this trial is testing

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis

Who this might be right for
Allergic Contact Dermatitis
Edesa Biotech Inc. 211
Testing effectiveness (Phase 2)Study completedNCT01720251
What this trial is testing

Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

Who this might be right for
Allergic RhinitisRhinoconjunctivitis
Anergis 240
Post-approval studies (Phase 4)Study completedNCT00561717
What this trial is testing

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Bayer 70
Large-scale testing (Phase 3)Ended earlyNCT04176185
What this trial is testing

A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber

Who this might be right for
Allergic Rhinoconjunctivitis
ALK-Abelló A/S 80
Large-scale testing (Phase 3)Study completedNCT00197262
What this trial is testing

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)

Who this might be right for
Rhinitis, Allergic, Seasonal
GlaxoSmithKline 288
Testing effectiveness (Phase 2)Study completedNCT01644617
What this trial is testing

A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)

Who this might be right for
Rhinitis, Allergic, PerennialRhinitis, Allergic, Nonseasonal
ALK-Abelló A/S 124
Large-scale testing (Phase 3)Study completedNCT00770315
What this trial is testing

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)

Who this might be right for
Rhinitis, AllergicConjunctivitis
ALK-Abelló A/S 784
Large-scale testing (Phase 3)Study completedNCT02596321
What this trial is testing

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma

Who this might be right for
AllergyAsthmaRhinitis
Abbott 112
Large-scale testing (Phase 3)Study completedNCT01700192
What this trial is testing

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)

Who this might be right for
Rhinitis, Allergic, PerennialRhinitis, Allergic, Nonseasonal
ALK-Abelló A/S 1,482
Testing effectiveness (Phase 2)Study completedNCT02377895
What this trial is testing

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
3E Therapeutics Corporation 73
Post-approval studies (Phase 4)Study completedNCT00160537
What this trial is testing

POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

Who this might be right for
Seasonal Allergic Rhinitis
UCB Pharma 200
Large-scale testing (Phase 3)Study completedNCT02132169
What this trial is testing

A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Who this might be right for
Atopic Disease (Including Allergic Conjunctivitis)
Aciex Therapeutics, Inc. 512
Large-scale testing (Phase 3)Study completedNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 691
Post-approval studies (Phase 4)Study completedNCT00296491
What this trial is testing

Study Of Allergic Rhinitis In Patients Who Also Have Asthma

Who this might be right for
Asthma
GlaxoSmithKline 725
Large-scale testing (Phase 3)Study completedNCT02870205
What this trial is testing

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)

Who this might be right for
Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. 1,176
Early research (Phase 1)Study completedNCT05061524
What this trial is testing

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases

Who this might be right for
Atopic Healthy SubjectsAdult Subjects with Mild Allergic Diseases
Yuhan Corporation 68
Early research (Phase 1)Study completedNCT02127801
What this trial is testing

Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants

Who this might be right for
Allergy
Regeneron Pharmaceuticals 74
Post-approval studies (Phase 4)Study completedNCT00519636
What this trial is testing

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Who this might be right for
Rhinitis, Allergic, Perennial
GlaxoSmithKline 360
Testing effectiveness (Phase 2)Study completedNCT04504279
What this trial is testing

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Forte Biosciences, Inc. 154
Large-scale testing (Phase 3)Study completedNCT02245360
What this trial is testing

Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

Who this might be right for
Seasonal Allergic Rhinitis
Abbott 107
Next Page